Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
USL261 for Seizure Clusters in the EMU
NCT01999777Phase 3Completed
- Sponsor
- UCB
- Start
- Nov 2013
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial of midazolam in seizure cluster (2 arms), sponsored by UCB. Primary endpoint: Number of Participants That Were Seizure-free at 6 hours. Started Nov 2013; status: completed.
02
Drugs
midazolam
03
Conditions
seizure cluster
Beyond the preview
Go deeper on NCT01999777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999777.